Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Thrombosis Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0049-3848(96)87301-4PMID 9054055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion.

  1995cited by this paper
• The VLDL receptor: wayward brother of the LDL receptor

  1995cited by this paper
• Molecular physiology of reverse cholesterol transport.

  1995cited by this paper
• Apolipoprotein E: structure-function relationships.

  1994cited by this paper
• High-density lipoprotein subclasses.

  1994cited by this paper
• Development of a density gradient ultracentrifugation technique for the resolution of plasma lipoproteins which avoids apo E dissociation.

  1994cited by this paper
• Physiological role and clinical relevance of high‐density lipoprotein subclasses

  1994cited by this paper
• Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.

  1994cited by this paper
• Platelets and the lipoproteins: native, modified and platelet modified lipoproteins.

  1994cited by this paper
• Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix.

  1993cited by this paper
• Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg).

  1993cited by this paper
• Conformation of apolipoprotein E in lipoproteins.

  1993cited by this paper
• Lactoferrin binding to human platelets.

  1993cited by this paper
• Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease.

  1993cited by this paper
• Concentration and distribution of apolipoproteins A-I and E in normolipidemic, WHHL and diet-induced hyperlipidemic rabbit sera.

  1992cited by this paper
• LDL binding sites on platelets differ from the "classical" receptor of nucleated cells.

  1992cited by this paper
• Lactoferrin specifically inhibits endocytosis of chylomicron remnants but not alpha-macroglobulin.

  1992cited by this paper
• Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein.

  1991cited by this paper
• Inhibition of platelet function by high-density lipoprotein from a patient with apolipoprotein E deficiency.

  1991cited by this paper
• Amino acid sequence of rabbit apolipoprotein E.

  1991cited by this paper
• The role of apoE in inhibitory effects of apoE‐rich HDL on platelet function

  1991cited by this paper
• High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.

  1990cited by this paper
• Protective effect of lipoproteins containing apoprotein A‐I on Cu2+ ‐ catalyzed oxidation of human low density lipoprotein

  1989cited by this paper
• Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis?

  1989cited by this paper
• Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation.

  1989cited by this paper
• Inhibition of platelet aggregation by abnormal high density lipoprotein particles in plasma from patients with hepatic cirrhosis.

  1989cited by this paper
• Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.

  1988cited by this paper
• Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis.

  1987cited by this paper
• Delipidation of plasma lipoproteins.

  1986cited by this paper
• Isolation and characterization of apolipoprotein E.

  1986cited by this paper
• High density lipoprotein-induced cardiac prostacyclin synthesis in vitro: relationship to cardiac arachidonate mobilization.

  1986cited by this paper
• Binding of high density lipoprotein to cultured fibroblasts after chemical alteration of apoprotein amino acid residues.

  1986cited by this paper
• Abnormal high density lipoproteins from patients with liver disease regulate cholesterol metabolism in cultured human skin fibroblasts.

  1984cited by this paper
• High density lipoprotein metabolism.

  1984cited by this paper
• Plasma lipoproteins: apolipoprotein structure and function.

  1984cited by this paper
• Total plasma apo E and high density lipoprotein apo E in survivors of myocardial infarction.

  1984cited by this paper
• Hyperreactivity by an enhancement of the arachidonate pathway of platelets treated with cholesterol-rich phospholipid-dispersions.

  1980cited by this paper
• Effect of cholesterol on production of thromboxane b2 by platelets in vitro.

  1980cited by this paper
• Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts.

  1979cited by this paper
• Stimulation of esterified cholesterol accumulation in tissue culture cells exposed to high density lipoproteins enriched in free cholesterol.

  1978cited by this paper
• Platelet hypersensitivity induced by cholesterol incorporation.

  1975cited by this paper

• APOB gene polymorphisms may affect the risk of minor or minimal bleeding complications in patients on warfarin maintaining therapeutic INR

  2019cites this paper
• An Evaluation of Blood Compatibility of Silver Nanoparticles

  2016cites this paper
• The in vitro effects of niacin on platelet biomarkers in human volunteers

  2010cites this paper
• Lipoprotein-Associated Proteins Involved in Platelet Signaling

  2006cites this paper
• Platelet Activation by Low Density Lipoprotein and High Density Lipoprotein

  2006cites this paper
• Modified Low-Density Lipoproteins and High-Density Lipoproteins

  2006cites this paper
• Cleavage of apolipoprotein E by membrane-type matrix metalloproteinase-1 abrogates suppression of cell proliferation.

  2006cites this paper
• The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity.

  2005cites this paper
• Polymorphisms of apolipoprotein E and angiotensin-converting enzyme genes and carotid atherosclerosis in heavy drinkers.

  2005cites this paper
• Both Apolipoprotein E and Immune Deficiency Exacerbate Neointimal Hyperplasia After Vascular Injury in Mice

  2002cites this paper
• Low Density Lipoprotein Receptor-related Protein Mediates Apolipoprotein E Inhibition of Smooth Muscle Cell Migration*

  2002cites this paper
• Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia DOI 10.1194/jlr.M200016-JLR200

  2002cites this paper
• Apolipoprotein E: a cholesterol transport protein with lipid transport-independent cell signaling properties.

  2001cites this paper
• Genetics strongly determines the wall thickness of the left and right carotid arteries

  1998cites this paper
• NIA/AIzA Conference on apolipoprotein E genotyping in Alzheimer's disease. Bibliography.

  1996cites this paper